Apontis Pharma AG (XTER:APPH) EV-to-EBITDA : -3.97 (As of Jun. 23, 2024)

Apontis Pharma AG EV-to-EBITDA Chart

Apontis Pharma AG Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial				54.13	-	5.64	-	-1.47

Competitive Comparison of Apontis Pharma AG's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Apontis Pharma AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apontis Pharma AG's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apontis Pharma AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Apontis Pharma AG's EV-to-EBITDA falls into.

Apontis Pharma AG EV-to-EBITDA Calculation

Apontis Pharma AG's EV-to-EBITDA for today is calculated as:

Apontis Pharma AG's current Enterprise Value is €51.11 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apontis Pharma AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-12.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apontis Pharma AG  (XTER:APPH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Apontis Pharma AG's PE Ratio for today is calculated as:

Apontis Pharma AG's share price for today is €8.66.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apontis Pharma AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.329.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Apontis Pharma AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Apontis Pharma AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Apontis Pharma AG (XTER:APPH) Business Description